Lipotoxicity and the gut-liver axis in NASH pathogenesis.
Marra F, Svegliati-Baroni G.
J Hepatol. 2018 Feb;68(2):280-295. doi: 10.1016/j.jhep.2017.11.014. Epub 2017 Nov 14.
Glucose metabolism impairment in Parkinson's disease.
Dai C, Tan C, Zhao L, Liang Y, Liu G, Liu H, Zhong Y, Liu Z, Mo L, Liu X, Chen L.
Brain Res Bull. 2023 Jul;199:110672. doi: 10.1016/j.brainresbull.2023.110672. Epub 2023 May 18.
Circadian hormone secretion of enteroendocrine cells: implication on pregnancy status.
Homeida AM, Homeida MA, Al-Suhaimi EA.
Front Endocrinol (Lausanne). 2023 May 10;14:1106382. doi: 10.3389/fendo.2023.1106382. eCollection 2023.
Understanding the Connection between Gut Homeostasis and Psychological Stress.
Zhang H, Wang Z, Wang G, Song X, Qian Y, Liao Z, Sui L, Ai L, Xia Y.
J Nutr. 2023 Apr;153(4):924-939. doi: 10.1016/j.tjnut.2023.01.026. Epub 2023 Jan 31.
All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.
Chatzipanagiotou O, Schizas D, Vailas M, Tsoli M, Sakarellos P, Sotiropoulou M, Papalambros A, Felekouras E.
J Neuroendocrinol. 2023 Apr;35(4):e13267. doi: 10.1111/jne.13267. Epub 2023 Apr 11.
Calcium metabolism.
Pak CY.
J Am Coll Nutr. 1989;8 Suppl:46S-53S. doi: 10.1080/07315724.1989.10737969.
Glucagon-like peptide-1 receptor agonist-based agents and weight loss composition: Filling the gaps.
Dubin RL, Heymsfield SB, Ravussin E, Greenway FL.
Diabetes Obes Metab. 2024 Dec;26(12):5503-5518. doi: 10.1111/dom.15913. Epub 2024 Sep 30.
The Metabolic and Endocrine Effects of a 12-Week Allulose-Rich Diet.
Cayabyab KB, Shin MJ, Heimuli MS, Kim IJ, D'Agostino DP, Johnson RJ, Koutnik AP, Bellissimo N, Diamond DM, Norwitz NG, Arroyo JA, Reynolds PR, Bikman BT.
Nutrients. 2024 Jun 10;16(12):1821. doi: 10.3390/nu16121821.
GLP-1 Analog Modulates Appetite, Taste Preference, Gut Hormones, and Regional Body Fat Stores in Adults with Obesity.
Kadouh H, Chedid V, Halawi H, Burton DD, Clark MM, Khemani D, Vella A, Acosta A, Camilleri M.
J Clin Endocrinol Metab. 2020 May 1;105(5):1552-63. doi: 10.1210/clinem/dgz140.
GLP-1 - Incretin and pleiotropic hormone with pharmacotherapy potential. Increasing secretion of endogenous GLP-1 for diabetes and obesity therapy.
Holst JJ, Jepsen SL, Modvig I.
Curr Opin Pharmacol. 2022 Apr;63:102189. doi: 10.1016/j.coph.2022.102189. Epub 2022 Feb 26.
